Inogen (NASDAQ: INGN) revenue
Inogen reported revenue of $348.7m for fiscal 2025, 3.9% more than in fiscal 2024 ($335.7m). Since fiscal 2016 its revenue has grown by 71.9%, an average growth of 6.2% a year.
Inogen has grown its revenue for 2 years in a row, and its best year of the last 10 was fiscal 2022. The biggest drop was in fiscal 2023, −16.3%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $348.7m | +3.9% | −$30.2m | −8.7% |
| 2024 | $335.7m | +6.4% | −$42.5m | −12.7% |
| 2023 | $315.7m | −16.3% | −$109.4m | −34.7% |
| 2022 | $377.2m | +5.4% | −$85.2m | −22.6% |
| 2021 | $358.0m | +16.1% | $9.2m | 2.6% |
| 2020 | $308.5m | −14.8% | −$12.0m | −3.9% |
| 2019 | $361.9m | +1.1% | $19.8m | 5.5% |
| 2018 | $358.1m | +43.6% | $37.9m | 10.6% |
| 2017 | $249.4m | +23.0% | $27.6m | 11.1% |
| 2016 | $202.8m | — | $22.9m | 11.3% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Inogen revenue compared with its sector
By revenue for its latest fiscal year, Inogen ranks 212th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Inogen, 3.9%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 210th | Arcutis Biotherapeutics | $376.1m | 91.3% |
| 211th | MannKind | $349.0m | 22.2% |
| 212th | Inogen | $348.7m | 3.9% |
| 213th | Castle Biosciences | $344.2m | 3.7% |
| 214th | Tactile Systems Technology | $329.5m | 12.5% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Inogen
- How much revenue did Inogen make in fiscal 2025?
- Inogen reported revenue of $348.7m for fiscal 2025, compared with $335.7m in fiscal 2024.
- How much has the revenue of Inogen grown?
- Between fiscal 2016 and fiscal 2025 it went from $202.8m to $348.7m: 71.9% more, an average growth of 6.2% a year.
- What was the best year for revenue at Inogen?
- Of its last 10 fiscal years, fiscal 2022, with $377.2m.
- Where does Inogen rank in its sector by revenue?
- It ranks 212th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Inogen come from?
- From the annual report (Form 10-K) that Inogen files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Inogen files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Inogen: the Inogen page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.